Using circulating tumor DNA to monitor myelodysplastic syndromes status

Hematol Oncol. 2019 Oct;37(4):531-533. doi: 10.1002/hon.2649. Epub 2019 Aug 11.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Circulating Tumor DNA / blood*
  • Circulating Tumor DNA / genetics
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / genetics
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / genetics

Substances

  • Circulating Tumor DNA